Followers | 2 |
Posts | 58 |
Boards Moderated | 0 |
Alias Born | 03/23/2017 |
Thursday, March 07, 2019 2:13:22 AM
I think there might be a misunderstanding regarding the funding issue, or to be more specific, the need for additional funding.
Enclosed file is from the previous September. See how it states that the funds were enough for Q1 2019 only. Now it’s Q2. ATM at work meanwhile. They have a fiduciary duty to write this since an ATM is not a secured funding. Just wanted you to understand this. This is a standard disclaimer and you will see this in every coming ER as long as they choose to tap into the ER in small increments when the share price is beneficial. Another reason (primary reason really) for tapping into the ATM slowly, is that it doesn’t influence the price to a large extent. In rough simple to remember numbers they have access to $35M (20 ATM, 5+5 China,5 cash). Current cash burn $4M/quarter. That equals to 2 full years and some more of operating capital all in all. So you see, any talk of funding being a concern is factually incorrect. If things proceed as they have (cut cash burn in more than half YOY and all other things improving), the company might even be profitable by then and this is the last financing ever needed.
Ofc, they could theoretically just skip the ATM and do another round of financing. Can’t rule that out, although that would be totally detrimental and unnecessary, right!
the previous er
Recent EKSO News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/12/2024 08:29:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 08:24:07 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 08/30/2024 09:30:16 PM
- Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering • GlobeNewswire Inc. • 08/30/2024 02:42:42 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/28/2024 01:25:19 PM
- Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal • GlobeNewswire Inc. • 08/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/29/2024 09:22:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/29/2024 08:55:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:39:19 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 08:39:17 PM
- Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024 • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/26/2024 08:15:48 PM
- Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024 • GlobeNewswire Inc. • 07/22/2024 12:00:00 PM
- Ekso Bionics Announces Research Partnership with Shepherd Center • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 09:28:29 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/03/2024 08:58:45 PM
- Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Ekso Bionics Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal • GlobeNewswire Inc. • 04/12/2024 12:00:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2024 09:14:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:08:54 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM